#136 How Did Diabetes Medications Become Obesity Meds? Beyond Journal Club on SURMOUNT-1 Trial
Core IM | Internal Medicine Podcast
The Role of GLP-1 and GIP Agonists in Diabetes Treatment
This chapter provides an introduction to GLP-1 and GIP agonists used in the treatment of diabetes. It discusses the different brand names and types of agonists, including semaglutide, liraglutide, and terzepitide. The chapter also mentions various trials such as LEDER, SUSTAIN, SOPRAS, and CERPAAS, which evaluated the cardiovascular and weight loss effects of these medications.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
